Coronary artery disease
Relation of Fractional Flow Reserve After Drug-Eluting Stent Implantation to One-Year Outcomes

https://doi.org/10.1016/j.amjcard.2011.02.329Get rights and content

Patients still present with drug-eluting stent (DES) failure despite an angiographically successful implantation. The aim of the present study was to investigate the relation between the fractional flow reserve (FFR) measured after DES implantation and the clinical outcomes at 1 year. A total of 80 patients (mean age 62 years, 74% men, 99 DESs) underwent coronary pressure measurement at maximum hyperemia after successful DES implantation. The composite of major adverse cardiac events (MACE), including death, myocardial infarction, and ischemia-driven target vessel revascularization was evaluated at 1 year. The patients were divided into 2 groups (low-FFR group, FFR ≤0.90 and high-FFR group, FFR >0.90) according to the median FFR. The mean poststent percent diameter stenosis was 11 ± 5% in the low-FFR group and 12 ± 3% in the high-FFR group (p = 0.31). Left anterior descending coronary artery lesions were more frequent in the low-FFR group than in the high-FFR group (82% vs 55%, p = 0.02). The mean stent length was greater in the low-FFR group than in the high-FFR group (38 ± 18 vs 28 ± 13 mm, p = 0.01). Six cases (7.5%) of MACE occurred during the 1-year follow-up. The rate of MACE was 12.5% in the low-FFR group and 2.5% in the high-FFR group (p <0.01). Receiver operating characteristic curves revealed 0.90 as the best cutoff of FFR after DES implantation for the prediction of 1-year MACE. In conclusion, a poststent FFR of ≤0.90 correlated with a greater adverse event rate at 1 year.

Section snippets

Methods

The study population consisted of 80 patients who underwent FFR measurement immediately after angiographically successful PCI with DES implantation in de novo coronary lesions. The angiographic success of PCI was defined as residual stenosis <20% by visual assessment with Thrombolysis In Myocardial Infarction grade 3 coronary flow and FFR ≥0.80. The patients were not eligible for enrollment if they had undergone intervention in the setting of primary or emergent PCI for acute coronary syndrome,

Results

The baseline clinical characteristics, angiographic characteristics, and quantitative coronary angiographic results are summarized in Table 1, Table 2. The average number of DESs deployed per target lesion was 1.2 ± 0.4. Three types of DESs were implanted (sirolimus-eluting stent, 51%; paclitaxel-eluting stent, 39%; and zotarolimus-eluting stent, 10%). No complications attributable to FFR measurement occurred in any of the studied patients. The patients were divided into 2 groups according to

Discussion

The results of the present study have revealed, first, that the 1-year clinical outcome after DES implantation correlated with the poststent FFR; and second, that an FFR cutoff of 0.90 might be a useful indicator in daily practice for optimal physiologic DES implantation.

Although DES use has significantly reduced the rate of restenosis after PCI, 5% to 10% of stented patients develop MACE within 12 months after optimal angiographic stent implantation.2 This might be due to angiographically

Acknowledgment

The authors thank Dr. Roberto Patarca for editorial help.

References (16)

There are more references available in the full text version of this article.

Cited by (75)

View all citing articles on Scopus

Y.-N. Kim received research grant RTI04-01-01 from the Regional Technology Innovation Program of the Ministry of Knowledge Economy (MKE), Seoul, Korea.

View full text